4
Changes in Ownership
Sarepta Therapeutics, Inc. Filed Acc 0001209191-23-054441
President & CEO bought 25,225 shares at an average $79.36 ($2,001,800)
From the SEC's structured data for this filing
Trades in this filing
INGRAM DOUGLAS S · President & CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-11-03 | Purchase : show line 1 in the form | +10,081 | $78.57 | $792,064 | 375,163 | D |
| 2023-11-03 | Purchase : show line 2 in the form | +11,060 | $79.70 | $881,482 | 386,223 | D |
| 2023-11-03 | Purchase : show line 3 in the form | +3,884 | $80.33 | $312,002 | 390,107 | D |
| 2023-11-03 | Purchase : show line 4 in the form | +200 | $81.26 | $16,252 | 390,307 | D |
| Open-market purchases · 25,225 sh · avg $79.36 · $2,001,800 | ||||||
Loading xslF345X05/doc4.xml…